Analyst Reco. Ipsen S.A. OTC Markets

Equities

Market Closed - OTC Markets Other stock markets 14:41:09 2024-07-17 EDT			5-day change	1st Jan Change
30.38 ^USD	-0.26%		+2.38%	+3.05%

07-11	CAC40: maintains gains after reassuring US inflation figures	CF
07-11	CAC40: rise without volume, W-Street at its zenith but falls back	CF

IPSEN : UBS remains positive ahead of quarterly results	06-26	CF
Ipsen: share price soars, UBS confirms its recommendation	06-12	CF
IPSEN : UBS remains Buy after FDA approval	06-12	CF
Ipsen: share price up, analyst raises target	05-14	CF
IPSEN : Barclays raises its target price	05-14	CF
IPSEN : Better-than-expected Q1; guidance unchanged	04-24
IPSEN : Ipsen’s underlying fundamentals remain promising	03-13
Deutsche Bank Reduces Ipsen PT, Keeps Hold Rating	02-16	MT
IPSEN : Deutsche Bank cuts its target	02-16	CF
IPSEN : UBS reiterates its buy recommendation	02-14	CF
IPSEN : In line Q4 sales; lower-than-expected 2024 guidance	02-08
IPSEN : Deutsche Bank lowers its target price	12-15	CF
IPSEN : Ipsen outlined some promising mid-term takeaways at the CMD	12-08
IPSEN : UBS remains Buy after CMD	12-08	CF
IPSEN : RBC maintains 'in-line performance' rating	11-29	CF
IPSEN : Jefferies downgrades recommendation to 'hold	11-20	CF
IPSEN : Modest Q3 sales growth; guidance unchanged	23-10-26
Ipsen: upbeat with broker upgrade	23-09-12	CF
UBS Upgrades Ipsen to Buy from Neutral, Boosts PT	23-09-12	MT
IPSEN : UBS raises its recommendation	23-09-12	CF

No results for this search

IPSEN : Better-than-expected Q1; guidance unchanged

April 24, 2024 at 10:50 am